These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32187428)

  • 21. The Role of the Medical School Training on Physician Opioid Prescribing Practices: Evidence from Ontario, Canada: Le rôle de la formation à la faculté de médecine à l'égard des pratiques de prescription d'opioïdes des médecins: données probantes d'Ontario, Canada.
    de Oliveira C; Iwajomo T; Gomes T; Kurdyak P
    Can J Psychiatry; 2020 Oct; 65(10):710-720. PubMed ID: 32508120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of infective endocarditis among people who inject drugs: a retrospective, population-based time series analysis.
    Weir MA; Slater J; Jandoc R; Koivu S; Garg AX; Silverman M
    CMAJ; 2019 Jan; 191(4):E93-E99. PubMed ID: 30692105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and associated factors of hepatitis C infection (HCV) in a multi-site Canadian population of illicit opioid and other drug users (OPICAN).
    Firestone Cruz M; Fischer B; Patra J; Kalousek K; Newton-Taylor B; Rehm J; Tyndall M
    Can J Public Health; 2007; 98(2):130-3. PubMed ID: 17441537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.
    Suryaprasad AG; White JZ; Xu F; Eichler BA; Hamilton J; Patel A; Hamdounia SB; Church DR; Barton K; Fisher C; Macomber K; Stanley M; Guilfoyle SM; Sweet K; Liu S; Iqbal K; Tohme R; Sharapov U; Kupronis BA; Ward JW; Holmberg SD
    Clin Infect Dis; 2014 Nov; 59(10):1411-9. PubMed ID: 25114031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid tolerance and urine drug testing among initiates of extended-release or long-acting opioids in Food and Drug Administration's Sentinel System.
    Larochelle MR; Cocoros NM; Popovic J; Dee EC; Kornegay C; Ju J; Racoosin JA
    J Opioid Manag; 2017; 13(5):315-327. PubMed ID: 29199397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors of infective endocarditis in persons who inject drugs.
    Shah M; Wong R; Ball L; Puka K; Tan C; Shojaei E; Koivu S; Silverman M
    Harm Reduct J; 2020 Jun; 17(1):35. PubMed ID: 32503573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Event-level analyses of sex-risk and injection-risk behaviors among nonmedical prescription opioid users.
    Zule WA; Oramasionwu C; Evon D; Hino S; Doherty IA; Bobashev GV; Wechsberg WM
    Am J Drug Alcohol Abuse; 2016 Nov; 42(6):689-697. PubMed ID: 27285847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescription opioid misuse and its relation to injection drug use and hepatitis C virus infection: protocol for a systematic review and meta-analysis.
    Jordan AE; Jarlais DD; Hagan H
    Syst Rev; 2014 Sep; 3():95. PubMed ID: 25178433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolving drug epidemic of prescription opioid injection and its association with HCV transmission among people who inject drugs in Montréal, Canada.
    Bruneau J; Arruda N; Zang G; Jutras-Aswad D; Roy É
    Addiction; 2019 Feb; 114(2):366-373. PubMed ID: 30399197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C.
    Whitehead AJ; Dobscha SK; Morasco BJ; Ruimy S; Bussell C; Hauser P
    J Pain Symptom Manage; 2008 Jul; 36(1):39-45. PubMed ID: 18358690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral Prescription Opioids as a High-Risk Indicator for Hepatitis C Infection: Another Step Toward HCV Elimination.
    Hack B; Timalsina U; Tefera E; Wilkerson B; Paku E; Fernandez S; Fishbein D
    J Prim Care Community Health; 2021; 12():21501327211034379. PubMed ID: 34467805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceutical opioid use among oral and intravenous users in Australia: A qualitative comparative study.
    Dertadian G; Iversen J; Dixon TC; Sotiropoulos K; Maher L
    Int J Drug Policy; 2017 Mar; 41():51-58. PubMed ID: 28107670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the impact of an opioid prescribing guideline for dentists in Ontario, Canada.
    Guan Q; Campbell T; Martins D; Tadrous M; Juurlink D; Paterson JM; Mamdani M; Mock D; Gomes T
    J Am Dent Assoc; 2020 Jan; 151(1):43-50. PubMed ID: 31813472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between prescription opioid dispensing and opioid-related morbidity and mortality in Ontario, Canada: an ecological study of public health units.
    Ladha KS; Wijeysundera DN; Wunsch H; Clarke H; Diep C; Gomes T
    Drug Alcohol Depend; 2021 Oct; 227():108989. PubMed ID: 34482045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017.
    Schieber LZ; Guy GP; Seth P; Young R; Mattson CL; Mikosz CA; Schieber RA
    JAMA Netw Open; 2019 Mar; 2(3):e190665. PubMed ID: 30874783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE Study.
    Litwin AH; Drolet M; Nwankwo C; Torrens M; Kastelic A; Walcher S; Somaini L; Mulvihill E; Ertl J; Grebely J
    J Viral Hepat; 2019 Sep; 26(9):1094-1104. PubMed ID: 31074167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Opioid Prescribing Habits Based on Analysis of a State Prescription Drug Monitoring Program.
    Alexander JC; Silge J; Jones S; Joshi GP
    Pain Physician; 2019 Sep; 22(5):E425-E433. PubMed ID: 31561654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends and uptake of new formulations of controlled-release oxycodone in Canada.
    Gomes T; Jain S; Paterson JM; Sketris I; Caetano P; Henry D;
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):520-525. PubMed ID: 29359446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of an mHealth Intervention on Hepatitis C Testing Uptake Among People With Opioid Use Disorder: Randomized Controlled Trial.
    Hochstatter KR; Gustafson DH; Landucci G; Pe-Romashko K; Cody O; Maus A; Shah DV; Westergaard RP
    JMIR Mhealth Uhealth; 2021 Feb; 9(2):e23080. PubMed ID: 33616545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
    Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ;
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.